Patent details

EP2189162 Title: Methods for the treatment of cellular proliferative disorders

Basic Information

Publication number:
EP2189162
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP101533743
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Methods for the treatment of cellular proliferative disorders
French Title of Invention:
Méthode pour le traitement des troubles de la prolifération cellulaire
German Title of Invention:
Verfahren zur Behandlung der zellulären proliferativen Erkrankungen
SPC Number:

Dates

Filing date:
26/10/2001
Grant date:
27/11/2013
EP Publication Date:
27/11/2013
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/05/2010
EP B1 Publication Date:
27/11/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/10/2014
Expiration date:
26/10/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/10/2001
 
 

Name:
Oncolytics Biotech Inc.
Address:
Suite 210 1167 Kensington Crescent N. W., Calgary, AB T2N 1X7, Canada (CA)

Inventor

Name:
Coffey Matthew, C.
Address:
Canada (CA)

Priority

Priority Number:
246728 P
Priority Date:
09/11/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 35/76;
Filing date Document type Number of pages